NovoBiome enters microbiome arena with AI tech primed to probe gut-liver link 10-May-2021 By Will Chu Newly formed NovoBiome becomes the latest firm to delve into the gut microbiome as it aims to harness Artificial Intelligence (AI) to develop Live Biotherapeutic Products (LBPs) that address liver conditions.